LOGEX Group is the European leader in advanced analytics for healthcare, serving providers, payors and authorities. The company has the most comprehensive product portfolio in its field in Europe, and the broadest geographical reach.
The company operates three main business units: Financial Analytics (e.g. cost, resource allocation, planning), Outcomes Analytics (e.g. healthcare quality outcome measurement and benchmarking) and Value Analytics (e.g. value-based benchmarking).
Key developments in 2019
During 2019, LOGEX Group strengthened its footprint in Sweden for Financial Analytics with the acquisition of Ensolution. 2019 has also been a year of integration after the 2018 merger. A new organizational structure and several key hires strengthened the organization. The company has re-focused the product portfolio to optimize for the core offering and developed the next generation Financial Analytics offering. LOGEX has also launched a number of marketing and branding projects to strengthen the communication around the company's purpose and value proposition.
The challenges we face
Healthcare systems globally are under pressure from increasing costs, whilst the need to improve quality is continuously increasing. There is a lack of transparency in both outcomes and costs in healthcare, which makes it very difficult to address these challenges.
What is the outcome?
The LOGEX Group offers a comprehensive software portfolio to support a holistic approach to improve healthcare through advanced analytics. It also enables stakeholders in the healthcare system to transition towards more quality-centric and cost-conscious healthcare through an unprecedented level of clarity on performance of outcomes and costs.
Who are the stakeholders?
LOGEX Group's core geographical markets are the Netherlands, Sweden, Finland, Norway and the UK. The company offers advanced analytics solutions that transform data into actionable insight, bringing clarity to decisions that lead to improved outcomes at lower cost. Thus, LOGEX Group's solutions benefit the healthcare system as a whole (including payors, providers and patients) by enabling a transition towards more quality centered and cost-efficient care.
How big is the effect, and does it last?
Approximately 600 providers are using LOGEX Group's platform and more than 18 million unique patients have been impacted by insights derived from the Group's analytic tools. The average improvement in financial health of providers using LOGEX Group's solutions is approximately 15%, demonstrating the effect that LOGEX Group has on its stakeholders.
If LOGEX didn’t exist…
Without LOGEX Group’s solutions, healthcare providers would not have the same level of clarity on the relative performance of their operations and data driven tools allowing them to effectively manage costs and quality of care. This could negatively impact the quality patients receive and thereby lead to suboptimal outcomes in terms of lower quality at higher cost, and greater variability.
Impact risk: what can go wrong?
The pace of transformation of healthcare systems towards quality centric care and value-based healthcare presents a potential risk for LOGEX Group. While there is evidence of a change starting to emerge, we are yet to reach the real inflection point for more rapid change. This is primarily a risk related to the less mature products in the portfolio focused on value-based healthcare.
Another risk LOGEX Group faces is related to data security and privacy. The company has invested heavily in order to maintain the highest security standards and have obtained several internationally recognized certifications. The total impact that LOGEX Group will achieve is also dependent on its ability to scale the technology and offering to new geographical markets.